Expert consensus on graded management of antineoplastic drugs

The standardized diagnosis and treatment of tumor and rational use of antineoplastic drugs are not only central issue of government and society, but also difficulty of medical quality control. In order to implement the Administrative Measures for Clinical Application of Antineoplastic Drugs (Trial) issued by National Health Commission of People's Republic of China, on basis of extensive investigation and through Delphi method and several rounds of expert discussion, an expert consensus on guiding road map and management points of drug classification was formed. Suggestions are provided to guide other medical institutions to do related work in graded management of antineoplastic drugs.